Antifungal susceptibility of Saccharomyces cerevisiae and …
Treatment efficacy was assessed by determining of CFUs/g in liver, kidney, brain, lung and spleen. Results: 5-Fluorocytosine was the most in vitro active compound followed by amphotericin B, voriconazole and anidulafungin.
Antifungal Susceptibility of Saccharomyces cerevisiae Isolated …
Commonly employed antifungal agents, such as fluconazole and amphotericin B, have played a main role in treatment. However, studies on the susceptibility profile of S. cerevisiae to antifungal drugs remain scarce, with noteworthy high minimum inhibitory concentration (MIC) values for fluconazole and itraconazole [8].
Saccharomyces cerevisiae fungemia in a critically ill patient …
Saccharomyces cerevisiae is an ascomycetes yeast, historically used to ferment sugars to produce varieties of food and beverages, and more recently as an ingredient in probiotic supplements used in the treatment and prevention of various diarrheal disorders .
Antifungal susceptibility of Saccharomyces cerevisiae and
According to the current guidelines, the recommended treatment for these infections consists of amphotericin B (AMB) or AMB plus 5-fluorocytosine (5FC) in the most severe cases, 2 but few studies have evaluated the efficacy of other antifungal agents.
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic …
Our results show that administration of S. cerevisiae CNCM I-3856 (live or inactivated cells) in the oral cavity of C57BL/6J mice resulted in a protective effect against oropharyngeal candidiasis. The strongest effect was obtained with live S. cerevisiae CNCM I-3856.
Isolate distribution and antifungal susceptibility of Saccharomyces ...
2024年9月14日 · S. cerevisiae can cause vulvovaginal candidiasis (VVC), but the difficulty of its treatment is no greater than that of Candida albicans. Azoles are still the recommended regimen for treating S. cerevisiae vulvovaginitis, and resistant isolates are usually susceptible to amphotericin B, for which vaginal effervescent tablets can be used.
Saccharomyces cerevisiae is a probiotic often used as dietary supplements and in food preparation. In this study, we explored the treatment modality of S. cerevisiae on oral candidiasis in 15 patients belonging to verum group (n = 10) and placebo group (n = 5). All 10 patients in verum group have recovered from the oral candidiasis in 2
Isolate distribution and antifungal susceptibility of Saccharomyces ...
2024年9月14日 · Azoles remain the recommended regimen for S. cerevisiae-related VVC, and the use of amphotericin B vaginal effervescent tablets could be considered for the treatment of azole-resistant isolates. The antifungal susceptibility of S. cerevisiae varies according to the isolated source, and the pathogeni …
[Urinary infection by Saccharomyces cerevisiae: Emerging yeast?]
Saccharomyces cerevisiae is a commensal yeast of the digestive, respiratory and genito-urinary tract. It is widely used as a probiotic for the treatment of post-antibiotic diarrhea. It most often occurs in immunocompromised patients frequently causing fungemia. We report the case of …
SACCHAROMYCES CEREVISIAE FUNGEMIA IN A PEDIATRIC …
2017年7月31日 · The treatment indicated for bloodstream infection associated with the use of probiotics is the removal of the contaminated central venous catheter and the use of Amphotericin B 1 mg/kg/day or Fluconazole 10 mg/kg/day, although some articles describe strains resistant to Fluconazole and even to Amphotericin B. 4 An article concerning the fungi ...